FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lanfranco Fattorini

Research Profile

Living Beings

Procedures

Microbial Sensitivity Tests

Chemicals & Drugs

Disorders

Anatomy

Geographic Areas

Italy

Co-author Network

Publications

TOP 3
Giovanni Piccaro; Perla Filippini; Federico Giannoni; Alessandro Mustazzolu; Lanfranco Fattorini
Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions.
Claudio Piersimoni; Stefano Bornigia; Giancarlo Gherardi; Federico Giannoni; Alessandro Mustazzolu; Lanfranco Fattorini
Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculum.
Elisabetta Iona; Roberto Nisini; Manuela Pardini; Annarita Stringaro; Raffaela Teloni; Lara Brunori; Marisa Colone; Lanfranco Fattorini; Maria Cristina Gagliardi; Federico Giannoni
Infection of human THP-1 cells with dormant Mycobacterium tuberculosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lanfranco Fattorini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Giovanni Piccaro; Perla Filippini; Federico Giannoni; Alessandro Mustazzolu; Lanfranco Fattorini
Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions.
Antimicrobial agents and chemotherapy 2013;57(3):1428-33.
2013: Claudio Piersimoni; Stefano Bornigia; Giancarlo Gherardi; Federico Giannoni; Alessandro Mustazzolu; Lanfranco Fattorini
Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculum.
Journal of clinical microbiology 2013;51(1):291-4.
2012: Elisabetta Iona; Roberto Nisini; Manuela Pardini; Annarita Stringaro; Raffaela Teloni; Lara Brunori; Marisa Colone; Lanfranco Fattorini; Maria Cristina Gagliardi; Federico Giannoni
Infection of human THP-1 cells with dormant Mycobacterium tuberculosis.
Microbes and infection / Institut Pasteur 2012;14(11):959-67.
2012: Paolo Miotto; ENRICO TORTOLI; Emanuele Borroni; Andrea M Cabibbe; Lanfranco Fattorini; Paola Mantegani; Giovanni Battista Migliori; Daniela Cirillo
GenoType MTBDRsl performance on clinical samples with diverse genetic background.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2012;40(3):690-8.
2012: Lanfranco Fattorini; Perla Filippini; Federico Giannoni; Giovanni Battista Migliori; Alessandro Mustazzolu; Manuela Pardini; Giovanni Piccaro; Giovanni Sotgiu; Emanuele Borroni; Daniela Maria Cirillo
Drug-resistant tuberculosis among foreign-born persons in Italy.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2012;40(2):497-500.
2011: Maryline Bonnet; Francesco Checchi; Lanfranco Fattorini; Thierry Jarosz; Francesca Meacci; Juliet Melzer; Stefan Niemann; Marco R Oggioni; Graziella Orefici; Germano Orrù; Manuela Pardini; Heinz Rinder; Sabine Rüsch-Gerdes; Peter W Andrew; Mike Barer; Hasan Yesilkaya; Francis Varaine
Treatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infection.
PloS one 2011;6(8):e23081.
2011: Elena Giacomini; Maria Elena Remoli; Marta Scandurra; Valérie Gafa; Manuela Pardini; Lanfranco Fattorini; Eliana M Coccia
Expression of proinflammatory and regulatory cytokines via NF-κB and MAPK-dependent and IFN regulatory factor-3-independent mechanisms in human primary monocytes infected by Mycobacterium tuberculosis.
Clinical & developmental immunology 2011;2011():841346.
2010: Perla Filippini; Elisabetta Iona; Giovanni Piccaro; Pascale Peyron; Olivier Neyrolles; Lanfranco Fattorini
Activity of drug combinations against dormant Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy 2010;54(6):2712-5.
2009: Manuela Pardini; Stefan Niemann; Francis Varaine; Elisabetta Iona; Francesca Meacci; Germano Orrù; Hasan Yesilkaya; Thierry Jarosz; Peter Andrew; Mike Barer; Francesco Checchi; Heinz Rinder; Graziella Orefici; Sabine Rüsch-Gerdes; Lanfranco Fattorini; Marco R Oggioni; Maryline Bonnet
Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern Europe.
Tuberculosis (Edinburgh, Scotland) 2009;89(4):317-24.
2009: Elena Giacomini; Maria Elena Remoli; Valérie Gafa; Manuela Pardini; Lanfranco Fattorini; Eliana M Coccia
IFN-beta improves BCG immunogenicity by acting on DC maturation.
Journal of leukocyte biology 2009;85(3):462-8.
2008: Carla Palma; Elisabetta Iona; Federico Giannoni; Manuela Pardini; Lara Brunori; Lanfranco Fattorini; Giuseppe Del Giudice; Antonio Cassone
The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-gamma response.
Vaccine 2008;26(33):4237-43.
2008: Lanfranco Fattorini; Elisabetta Iona; Daniela Cirillo; Giovanni Battista Migliori; Graziella Orefici; M Aziz; A Wright; Silva TAFAJ; B Baig; G Mulliqi; S Maungate; Z Cuna; S Al-Busaidy; Z Al-Suwaidi; I Ceyhan
External quality control of Mycobacterium tuberculosis drug susceptibility testing: results of two rounds in endemic countries.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2008;12(2):214-7.
2007: Elisabetta Iona; Federico Giannoni; Lara Brunori; Michele de Gennaro; Romano Mattei; Lanfranco Fattorini
Isolation of Nocardia asiatica from cutaneous ulcers of a human immunodeficiency virus-infected patient in Italy.
Journal of clinical microbiology 2007;45(6):2088-9.
2007: Carla Palma; Elisabetta Iona; Federico Giannoni; Manuela Pardini; Lara Brunori; Graziella Orefici; Lanfranco Fattorini; Antonio Cassone
The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
Cellular microbiology 2007;9(6):1455-65.
2007: Lanfranco Fattorini
[Strategies for the development of new tuberculosis vaccines].
Minerva medica 2007;98(2):109-19.
2007: Elisabetta Iona; Federico Giannoni; Manuela Pardini; Lara Brunori; Graziella Orefici; Lanfranco Fattorini
Metronidazole plus rifampin sterilizes long-term dormant Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy 2007;51(4):1537-40.
2007: Claudio Piersimoni; Carla Lacchini; Valeria Penati; Elisabetta Iona; Lanfranco Fattorini; Domenico Nista; Diego Zallocco; Gian Pietro Gesu; Luigi Codecasa
Validation of the agar proportion and 2 liquid systems for testing the susceptibility of Mycobacterium tuberculosis to moxifloxacin.
Diagnostic microbiology and infectious disease 2007;57(3):283-7.
2007: Manuela Pardini; Francis Varaine; C Hewison; Elisabetta Iona; Marco Pataracchia; Graziella Orefici; Lanfranco Fattorini
Pyrazinamide resistance in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Abkhazia.
Journal of chemotherapy (Florence, Italy) 2007;19(1):106-7.
2007: Manuela Pardini; Francis Varaine; Maryline Bonnet; Graziella Orefici; Marco R Oggioni; Lanfranco Fattorini
Usefulness of the BACTEC MGIT 960 system for isolation of mycobacterium tuberculosis from sputa subjected to long-term storage.
Journal of clinical microbiology 2007;45(2):575-6.
2007: Lanfranco Fattorini; Giovanni Battista Migliori; Antonio Cassone
Extensively drug-resistant (XDR) tuberculosis: an old and new threat.
Annali dell'Istituto superiore di sanità 2007;43(4):317-9.
2006: Manuela Pardini; Federico Giannoni; Carla Palma; Elisabetta Iona; Aurelio Aurelio Cafaro; Lara Brunori; Monica Rinaldi; Vito Michele Fazio; Maria Elena Laguardia; Damiano Cosimo Carbonella; Mauro Magnani; Barbara Ensoli; Lanfranco Fattorini; Antonio Cassone
Immune response and protection by DNA vaccines expressing antigen 85B of Mycobacterium tuberculosis.
FEMS microbiology letters 2006;262(2):210-5.
2006: Elena Giacomini; Ambar Sotolongo; Elisabetta Iona; Martina Severa; Maria Elena Remoli; Valérie Gafa; Roberto Lande; Lanfranco Fattorini; Issar Smith; Riccardo Manganelli; Eliana M Coccia
Infection of human dendritic cells with a Mycobacterium tuberculosis sigE mutant stimulates production of high levels of interleukin-10 but low levels of CXCL10: impact on the T-cell response.
Infection and immunity 2006;74(6):3296-304.
2005: Francesca Meacci; Germano Orrù; Elisabetta Iona; Federico Giannoni; Claudio Piersimoni; Gianni Pozzi; Lanfranco Fattorini; Marco R Oggioni
Drug resistance evolution of a Mycobacterium tuberculosis strain from a noncompliant patient.
Journal of clinical microbiology 2005;43(7):3114-20.
2005: Federico Giannoni; Elisabetta Iona; Federica Sementilli; Lara Brunori; Manuela Pardini; Giovanni Battista Migliori; Graziella Orefici; Lanfranco Fattorini
Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy 2005;49(7):2928-33.
2005: Maria Cristina Gagliardi; Raffaela Teloni; Federico Giannoni; Manuela Pardini; Valeria Sargentini; Lara Brunori; Lanfranco Fattorini; Roberto Nisini
Mycobacterium bovis Bacillus Calmette-Guerin infects DC-SIGN- dendritic cell and causes the inhibition of IL-12 and the enhancement of IL-10 production.
Journal of leukocyte biology 2005;78(1):106-13.
2005: Daniela Isola; Manuela Pardini; Francis Varaine; Stefan Niemann; Sabine Rüsch-Gerdes; Lanfranco Fattorini; Graziella Orefici; Francesca Meacci; Claudia Trappetti; Marco Rinaldo Oggioni; Germano Orrù
A Pyrosequencing assay for rapid recognition of SNPs in Mycobacterium tuberculosis embB306 region.
Journal of microbiological methods 2005;62(1):113-20.
2005: Manuela Pardini; Elisabetta Iona; Francis Varaine; Hayk Karakozian; Herchanik Arzumanian; Lara Brunori; Graziella Orefici; Lanfranco Fattorini
Mycobacterium tuberculosis drug resistance, Abkhazia.
Emerging infectious diseases 2005;11(3):501-3.
2005: Manuela Pardini; Francis Varaine; Elisabetta Iona; Erchanik Arzumanian; Francesco Checchi; Marco R Oggioni; Graziella Orefici; Lanfranco Fattorini
Cetyl-pyridinium chloride is useful for isolation of Mycobacterium tuberculosis from sputa subjected to long-term storage.
Journal of clinical microbiology 2005;43(1):442-4.
2004: Lara Brunori; Federico Giannoni; Luca Bini; Sabrina Liberatori; Cristiane Frota; Peter Jenner; Ove Fredrik Thoresen; Graziella Orefici; Lanfranco Fattorini
Induction of Mycobacterium avium proteins upon infection of human macrophages.
Proteomics 2004;4(10):3078-83.
2004: Maria Cristina Gagliardi; Raffaela Teloni; Sabrina Mariotti; Elisabetta Iona; Manuela Pardini; Lanfranco Fattorini; Graziella Orefici; Roberto Nisini
Bacillus Calmette-Guérin shares with virulent Mycobacterium tuberculosis the capacity to subvert monocyte differentiation into dendritic cell: implication for its efficacy as a vaccine preventing tuberculosis.
Vaccine 2004;22(29-30):3848-57.
2004: Sabrina Mariotti; Raffaela Teloni; Elisabetta Iona; Lanfranco Fattorini; Giulia Romagnoli; Maria Cristina Gagliardi; Graziella Orefici; Roberto Nisini
Mycobacterium tuberculosis diverts alpha interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells.
Infection and immunity 2004;72(8):4385-92.
2004: Lanfranco Fattorini; Renato Gennaro; Margherita Zanetti; Dejiang Tan; Lara Brunori; Federico Giannoni; Manuela Pardini; Graziella Orefici
In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis.
Peptides 2004;25(7):1075-7.
2004: Riccardo Manganelli; Lanfranco Fattorini; Dejiang Tan; Elisabetta Iona; Graziella Orefici; Giuseppe Altavilla; Paola Cusatelli; Issar Smith
The extra cytoplasmic function sigma factor sigma(E) is essential for Mycobacterium tuberculosis virulence in mice.
Infection and immunity 2004;72(5):3038-41.
2004: Giovanni Battista Migliori; Rosella Centis; Lanfranco Fattorini; Giorgio Besozzi; Cesare Saltini; Claudio Scarparo; Daniela Cirillo; Andrea Gori; Antonio Cassone; Claudio Piersimoni
Mycobacterium tuberculosis complex drug resistance in Italy.
Emerging infectious diseases 2004;10(4):752-3.
2004: Delia Goletti; Stefania Carrara; Donatella Vincenti; Elena Giacomini; Lanfranco Fattorini; Anna Rosa Garbuglia; Maria Rosaria Capobianchi; Tonino Alonzi; Gian Maria Fimia; Maurizio Federico; Guido Poli; Eliana M Coccia
Inhibition of HIV-1 replication in monocyte-derived macrophages by Mycobacterium tuberculosis.
The Journal of infectious diseases 2004;189(4):624-33.
2003: Francesco Dieli; Masaru Taniguchi; Mitchell Kronenberg; Stephane Sidobre; Juraj Ivanyi; Lanfranco Fattorini; Elisabetta Iona; Graziella Orefici; Giacomo De Leo; Domenica Russo; Nadia Caccamo; Guido Sireci; Caterina Di Sano; Alfredo Salerno
An anti-inflammatory role for V alpha 14 NK T cells in Mycobacterium bovis bacillus Calmette-Guérin-infected mice.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(4):1961-8.
2003: Giovanni Battista Migliori; Rosella Centis; Lanfranco Fattorini; Giorgio Besozzi; Cesare Saltini; Graziella Orefici; Claudio Piersimoni; Andrea Gori; A Cassone
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2003;21(1):129-34.
2003: Lanfranco Fattorini; Dejiang Tan; Elisabetta Iona; Maurizio Mattei; Federico Giannoni; Lara Brunori; Simona Recchia; Graziella Orefici
Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice.
Antimicrobial agents and chemotherapy 2003;47(1):360-2.
2002: Laura Rindi; Lanfranco Fattorini; Daniela Bonanni; Elisabetta Iona; Giulia Freer; Dejiang Tan; Gianni Dehò; Graziella Orefici; Carlo Garzelli
Involvement of the fadD33 gene in the growth of Mycobacterium tuberculosis in the liver of BALB/c mice.
Microbiology (Reading, England) 2002;148(Pt 12):3873-80.
2002: Lanfranco Fattorini; Roberta Creti; Roberto Nisini; Roberta Pietrobono; Yuming Fan; Annarita Stringaro; Giuseppe Arancia; Ottaviano Serlupi-Crescenzi; Elisabetta Iona; Graziella Orefici
Recombinant GroES in combination with CpG oligodeoxynucleotides protects mice against Mycobacterium avium infection.
Journal of medical microbiology 2002;51(12):1071-9.
2002: Sabrina Mariotti; Raffaela Teloni; Elisabetta Iona; Lanfranco Fattorini; Federico Giannoni; Giulia Romagnoli; Graziella Orefici; Roberto Nisini
Mycobacterium tuberculosis subverts the differentiation of human monocytes into dendritic cells.
European journal of immunology 2002;32(11):3050-8.
2002: Lanfranco Fattorini; Roberto Nisini; Yuming Fan; Yong-Jun Li; Dejiang Tan; Sabrina Mariotti; Raffaela Teloni; Elisabetta Iona; Graziella Orefici
Exposure of BALB/c mice to low doses of Mycobacterium avium increases resistance to a subsequent high-dose infection.
Microbiology (Reading, England) 2002;148(Pt 10):3173-81.
2002: Giovanni Battista Migliori; Lanfranco Fattorini; Patrizia Vaccarino; Giorgio Besozzi; Cesare Saltini; Graziella Orefici; Elisabetta Iona; Alberto Matteelli; Fiorino Fiorentini; Luigi Codecasa; Lucio Casali; A Cassone
Prevalence of resistance to anti-tuberculosis drugs: results of the 1998/99 national survey in Italy.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2002;6(1):32-8.
2001: Anna Giuliani; Salvatore Pasquale Prete; Grazia Graziani; Angelo Aquino; Alessandra Balduzzi; M Sugita; MB Brenner; Elisabetta Iona; Lanfranco Fattorini; Graziella Orefici; Steven A Porcelli; Enzo Bonmassar
Influence of Mycobacterium bovis bacillus Calmette Guérin on in vitro induction of CD1 molecules in human adherent mononuclear cells.
Infection and immunity 2001;69(12):7461-70.
2001: Elena Giacomini; Elisabetta Iona; L Ferroni; M Miettinen; Lanfranco Fattorini; Graziella Orefici; Ilkka Julkunen; Eliana M Coccia
Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(12):7033-41.
2001: Salvatore Pasquale Prete; Anna Giuliani; Elisabetta Iona; Lanfranco Fattorini; Graziella Orefici; Ornella Franzese; Enzo Bonmassar; Grazia Graziani
Bacillus Calmette-Guerin down-regulates CD1b induction by granulocyte-macrophage colony stimulating factor in human peripheral blood monocytes.
Journal of chemotherapy (Florence, Italy) 2001;13(1):52-8.
2000: Lanfranco Fattorini; Lucilla Baldassarri; Y J Li; Maria Grazia Ammendolia; Yuming Fan; Simona Recchia; Elisabetta Iona; Graziella Orefici
Virulence and drug susceptibility of Mycobacterium celatum.
Microbiology (Reading, England) 2000;146 ( Pt 11)():2733-42.
2000: Giovanni Battista Migliori; Marco Ambrosetti; Lanfranco Fattorini; Valeria Penati; Patrizia Vaccarino; Giorgio Besozzi; L Ortona; Cesare Saltini; Graziella Orefici; Maria Luisa Moro; E Lona; A Cassone
Surveillance of anti-tuberculosis drug resistance: results of the 1998/1999 proficiency testing in Italy. SMIRA (Italian Multicentre Study on Antituberculosis Drug Resistance) Study Group.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2000;4(10):940-6.
1999: Angelo Corti; Lanfranco Fattorini; Ove Fredrik Thoresen; Maria Luisa Ricci; A Gallizia; M Pelagi; Y Li; Graziella Orefici
Upregulation of p75 tumor necrosis factor alpha receptor in Mycobacterium avium-infected mice: evidence for a functional role.
Infection and immunity 1999;67(11):5762-7.
1999: Lanfranco Fattorini; Maurizio Mattei; Roberta Placido; B Li; Elisabetta Iona; Umberto Agrimi; Vittorio Colizzi; Graziella Orefici
Mycobacterium avium infection in BALB/c and SCID mice.
Journal of medical microbiology 1999;48(6):577-83.
1999: Gianni Pozzi; M Meloni; Elisabetta Iona; Germano Orrù; Ove Fredrik Thoresen; Maria Luisa Ricci; Marco R Oggioni; Lanfranco Fattorini; Graziella Orefici
rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy.
Journal of clinical microbiology 1999;37(4):1197-9.
1999: Lanfranco Fattorini; Elisabetta Iona; Maria Luisa Ricci; Ove Fredrik Thoresen; Germano Orrù; Marco R Oggioni; ENRICO TORTOLI; Claudio Piersimoni; P Chiaradonna; M Tronci; Gianni Pozzi; Graziella Orefici
Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis.
Microbial drug resistance (Larchmont, N.Y.) 1999;5(4):265-70.
1999: Lanfranco Fattorini; Y Xiao; Maurizio Mattei; Y Li; Elisabetta Iona; Ove Fredrik Thoresen; Graziella Orefici
Activities of eighteen antimicrobial regimens against Mycobacterium avium infection in beige mice.
Microbial drug resistance (Larchmont, N.Y.) 1999;5(3):227-33.
1998: Nicoletta Lari; M Cavallini; Laura Rindi; Elisabetta Iona; Lanfranco Fattorini; Carlo Garzelli
Typing of human Mycobacterium avium isolates in Italy by IS1245-based restriction fragment length polymorphism analysis.
Journal of clinical microbiology 1998;36(12):3694-7.
1998: Lanfranco Fattorini; Y Xiao; Maurizio Mattei; Y Li; Elisabetta Iona; Maria Luisa Ricci; Ove Fredrik Thoresen; Roberta Creti; Graziella Orefici
Activities of isoniazid alone and in combination with other drugs against Mycobacterium avium infection in beige mice.
Antimicrobial agents and chemotherapy 1998;42(3):712-4.
1996: Fabio Babiloni; Claudio Babiloni; Filippo Carducci; Lanfranco Fattorini; Paolo Onorati; A Urbano
Spline Laplacian estimate of EEG potentials over a realistic magnetic resonance-constructed scalp surface model.
Electroencephalography and clinical neurophysiology 1996;98(4):363-73.
1996: Lanfranco Fattorini; Y Xiao; Clara Maria Ausiello; Francesca Urbani; A laSala; M Mattei; Graziella Orefici
Late acquisition of hyporesponsiveness to lipopolysaccharide by Mycobacterium avium-infected human macrophages in producing tumor necrosis factor-alpha but not interleukin-1 beta and -6.
The Journal of infectious diseases 1996;173(4):1030-4.
1996: Lanfranco Fattorini; Véronique Vincent; B Li; Y Xiao; A Varnerot; ENRICO TORTOLI; Claudio Piersimoni; F Mandler; Maria Teresa Mascellino; Elisabetta Iona; Graziella Orefici
Type frequency and antimicrobial susceptibility of Mycobacterium avium-intracellulare complex strains isolated in Italy from AIDS and non-AIDS patients.
Journal of chemotherapy (Florence, Italy) 1996;8(1):37-42.
1995: Marco R Oggioni; Lanfranco Fattorini; B Li; Angelo De Milito; Maurizio Zazzi; Gianni Pozzi; Graziella Orefici; Pier Egisto Valensin
Identification of Mycobacterium tuberculosis complex, Mycobacterium avium and Mycobacterium intracellulare by selective nested polymerase chain reaction.
Molecular and cellular probes 1995;9(5):321-6.
1995: Giancarlo Filligoi; L Capitanio; Fabio Babiloni; Lanfranco Fattorini; A Urbano; Sergio Cerutti
Reduction of ocular artefacts in source current density brain mappings by ARX2 filtering.
Medical engineering & physics 1995;17(4):282-90.
1995: B Wagner; Lanfranco Fattorini; M Wagner; S H Jin; R Stracke; Gianfranco Amicosante; Nicola Franceschini; Graziella Orefici
Antigenic properties and immunoelectron microscopic localization of Mycobacterium fortuitum beta-lactamase.
Antimicrobial agents and chemotherapy 1995;39(3):739-45.
1995: Lanfranco Fattorini; B Li; Claudio Piersimoni; ENRICO TORTOLI; Y Xiao; C Santoro; Maria Luisa Ricci; Graziella Orefici
In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium.
Antimicrobial agents and chemotherapy 1995;39(3):680-5.
1995: Fabio Babiloni; Claudio Babiloni; Lanfranco Fattorini; Filippo Carducci; Paolo Onorati; A Urbano
Performances of surface Laplacian estimators: a study of simulated and real scalp potential distributions.
Brain topography 1995;8(1):35-45.
1994: Moreno Galleni; Nicola Franceschini; Birgit Quinting; Lanfranco Fattorini; G Orefici; Arduino Oratore; Jean-Marie Frère; Gianfranco Amicosante
Use of the chromosomal class A beta-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory beta-lactam compounds.
Antimicrobial agents and chemotherapy 1994;38(7):1608-14.
1994: J Timm; Mariagrazia Perilli; C Duez; J Trias; G Orefici; Lanfranco Fattorini; Gianfranco Amicosante; Arduino Oratore; B Joris; Jean-Marie Frère
Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitum beta-lactamase genes cloned from a natural isolate and a high-level beta-lactamase producer.
Molecular microbiology 1994;12(3):491-504.
1994: L Capitanio; Giancarlo Filligoi; D Liberati; Sergio Cerutti; Fabio Babiloni; Lanfranco Fattorini; A Urbano
ARX filtering of single-sweep movement-related brain macropotentials in mono- and multi-channel recordings.
Methods of information in medicine 1994;33(1):28-31.
1994: Franca Scopetti; Elisabetta Iona; Lanfranco Fattorini; A Goglio; Nicola Franceschini; Gianfranco Amicosante; Graziella Orefici
Activity of antimicrobial drugs evaluated by agar dilution and radiometric methods against strains of Nocardia asteroides isolated in Italy from immunocompromised patients.
Journal of chemotherapy (Florence, Italy) 1994;6(1):29-34.
1994: Lanfranco Fattorini; Y Xiao; B Li; C Santoro; F Ippoliti; Graziella Orefici
Induction of IL-1 beta, IL-6, TNF-alpha, GM-CSF and G-CSF in human macrophages by smooth transparent and smooth opaque colonial variants of Mycobacterium avium.
Journal of medical microbiology 1994;40(2):129-33.
1992: Lanfranco Fattorini; Graziella Orefici; S H Jin; G Scardaci; Gianfranco Amicosante; Nicola Franceschini; I Chopra
Resistance to beta-lactams in Mycobacterium fortuitum.
Antimicrobial agents and chemotherapy 1992;36(5):1068-72.
1992: Lanfranco Fattorini; C Q Hu; S H Jin; C Santoro; A Y Tsang; Maria Teresa Mascellino; F Mandler; Graziella Orefici
Activity of antimicrobial agents against Mycobacterium avium-intracellulare complex (MAC) strains isolated in Italy from AIDS-patients.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1992;276(4):512-20.
1991: Maria Teresa Mascellino; Elisabetta Iona; Lanfranco Fattorini; P De Gregoris; C Q Hu; C Santoro; Graziella Orefici
In vitro activity of clarithromycin alone or in combination with other antimicrobial agents against Mycobacterium avium-intracellulare. Complex strains isolated from AIDS patients.
Journal of chemotherapy (Florence, Italy) 1991;3(6):357-62.
1991: Lanfranco Fattorini; G Scardaci; S H Jin; Gianfranco Amicosante; Nicola Franceschini; Arduino Oratore; Graziella Orefici
Beta-lactamase of Mycobacterium fortuitum: kinetics of production and relationship with resistance to beta-lactam antibiotics.
Antimicrobial agents and chemotherapy 1991;35(9):1760-4.
1990: Gianfranco Amicosante; Nicola Franceschini; Bernardetta Segatore; Arduino Oratore; Lanfranco Fattorini; G Orefici; J Van Beeumen; Jean-Marie Frere
Characterization of a beta-lactamase produced in Mycobacterium fortuitum D316.
The Biochemical journal 1990;271(3):729-34.
1989: Lanfranco Fattorini; Gianfranco Amicosante; D Fiorentino; Nicola Franceschini; Luisa Di Marzio; Arduino Oratore; Graziella Orefici
Inhibitors and inactivators of beta-lactamase from Mycobacterium fortuitum.
Journal of chemotherapy (Florence, Italy) 1989;1(5):293-7.
1989: Lanfranco Fattorini; Gianfranco Amicosante; D Fiorentino; Nicola Franceschini; Arduino Oratore; Graziella Orefici
In vitro activity of some beta-lactams in combination with dicloxacillin against Mycobacterium fortuitum.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):339-41.
1989: Lanfranco Fattorini; D Fiorentino; Gianfranco Amicosante; Nicola Franceschini; Arduino Oratore; Graziella Orefici
Beta-lactamase production and biological characteristics in nitrosoguanidine induced Mycobacterium fortuitum mutants.
Acta leprologica 1989;7 Suppl 1():44-7.
1987: Lanfranco Fattorini; Gianfranco Amicosante; B Oliva; Arduino Oratore; Graziella Orefici
Beta-lactamase activity of Mycobacterium fortuitum.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987;6(2 Suppl):204-6.
1987: Lanfranco Fattorini; D Fiorentino; Nicola Franceschini; Gianfranco Amicosante; Graziella Orefici
[Mycobacterium fortuitum beta-lactamases: introduction to the problem and first experimental data on their purification and characterization].
Annali dell'Istituto superiore di sanità 1987;24(2):349-54.
1986: Lanfranco Fattorini; B Oliva; G Orefici
Expression and some properties of beta-lactamase from Mycobacterium fortuitum.
Drugs under experimental and clinical research 1986;12(12):973-7.